Coya Therapeutics
Develops Treg-focused therapies for neurodegenerative and immune-mediated diseases.
$4.57
After-hours close−0.02 (−0.52%)
At close$4.60(−5.45%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 34.67%8.13M sharesInsiders 0.12%27.6K sharesOther 65.21%15.30M shares
Shares outstanding 23.46M · Float 20.01M · 85.3% free float
Institutions13F, as of Mar 31, 2026
58 holders · 8.13M shares · 13 new positions · 33 increased · 11 reduced · 14 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Dme Capital Management, LP | 2.34M | 9.96% | +309.6K | May 15, 2026 |
| Aigh Capital Management LLC | 975.4K | 4.16% | 0 | Apr 30, 2026 |
| Vanguard Capital Management LLC | 844.9K | 3.60% | +844.9Knew | May 15, 2026 |
| Alyeska Investment Group, L.P. | 800.0K | 3.41% | 0 | May 15, 2026 |
| Prosight Management, LP | 420.4K | 1.79% | +420.4Knew | May 15, 2026 |
| CM Management, LLC | 375.0K | 1.60% | +25.0K | May 8, 2026 |
| Private Management Group Inc | 369.1K | 1.57% | +88.8K | May 8, 2026 |
| Geode Capital Management, LLC | 233.4K | 1.00% | +35.4K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Dr. Reddy's Laboratories, Inc. | 9.70% | 2.27M | 13G | Mar 12, 2026 ↗ |
| DME Capital Management, LP | 7.60% | 1.27M | 13G | Feb 14, 2025 ↗ |
| Orin Hirschman | 5.30% | 1.11M | 13G | Jan 28, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Dov A. Md Goldstein | director | 27.6K | 0.12% | Aug 19, 2025 |
10 people have not refiled in the last 18 months (1.18M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.